Compare DEI & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DEI | INVA |
|---|---|---|
| Founded | 1971 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2006 | 2000 |
| Metric | DEI | INVA |
|---|---|---|
| Price | $11.33 | $21.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $12.94 | ★ $32.80 |
| AVG Volume (30 Days) | ★ 1.5M | 631.5K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.06% | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | N/A | ★ 1.25 |
| Revenue | ★ $1,003,982,000.00 | $217,217,000.00 |
| Revenue This Year | $1.70 | $8.95 |
| Revenue Next Year | $2.35 | $12.65 |
| P/E Ratio | ★ N/A | $16.86 |
| Revenue Growth | 1.77 | ★ 62.63 |
| 52 Week Low | $9.04 | $16.52 |
| 52 Week High | $16.94 | $25.15 |
| Indicator | DEI | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 38.93 | 53.82 |
| Support Level | $11.22 | $20.44 |
| Resistance Level | $12.42 | $21.91 |
| Average True Range (ATR) | 0.24 | 0.34 |
| MACD | -0.04 | 0.06 |
| Stochastic Oscillator | 8.15 | 71.84 |
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.